ADRB2 rs1042580: Understanding Your Genetic Variant
The rs1042580 variant is a common genetic change located within the ADRB2 gene. It is primarily studied for its potential role in regulating the function of the beta-2 adrenergic receptor and how individuals may respond to certain asthma medications.
What each genotype means
Common genetic variant
This genotype is the most frequently observed form of this variant in many populations. Research has investigated this variant in the context of cardiovascular health, though its specific clinical impact remains a subject of ongoing study. Please discuss any concerns regarding your cardiovascular health or medication management with your clinician.
This is a common genotype found across diverse global populations.
Common genetic variant
Carrying one copy of each allele is a common occurrence for this genetic marker. While some studies have explored potential links between this variant and cardiovascular outcomes, the evidence is not definitive and may depend on other genetic or environmental factors. You should consult with a healthcare provider if you have questions about how your genetics might relate to your health profile.
This heterozygous genotype is frequently observed in the general population.
Common genetic variant
This genotype represents the alternative form of this variant. Scientific literature has examined this marker in relation to cardiovascular events, but findings are often mixed or require specific combinations with other genetic factors to show significance. Always consult with a qualified medical professional or pharmacist before making any changes to your health or medication regimen.
This genotype is present at a moderate frequency in the general population.
What is rs1042580 and Where is it Located?
The rs1042580 variant is a single nucleotide polymorphism (SNP) found within the ADRB2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. The ADRB2 gene is located on chromosome 5 and provides the instructions for creating the beta-2 adrenergic receptor. This receptor is a protein found on the surface of various cells throughout the body, including those in the smooth muscles of the airways. Because rs1042580 sits within this gene, researchers investigate whether this specific change in the DNA code alters the structure or the amount of the receptor protein produced, which could theoretically influence how the body reacts to signals that normally trigger these receptors.
The Role of the ADRB2 Gene
The ADRB2 gene encodes the beta-2 adrenergic receptor, which is a critical component of the sympathetic nervous system. When substances like epinephrine or certain medications bind to these receptors, they trigger a cascade of events that lead to the relaxation of smooth muscles. In the context of the lungs, this process is essential for bronchodilation, which helps open the airways and makes breathing easier. Because of this function, the ADRB2 gene is a major focus in respiratory research. Variations in this gene are frequently studied to see if they contribute to differences in how people experience asthma symptoms or how their bodies respond to common treatments, such as beta-agonist inhalers, which are designed to stimulate these receptors.
Research Associations and Evidence Strength
Scientific research into rs1042580 has explored its potential impact on asthma management and drug response. While the ADRB2 gene is well-established as a target for asthma therapy, the evidence linking rs1042580 specifically to clinical outcomes is considered moderate. Some studies have suggested that certain genotypes might be associated with variations in bronchodilator response, but results across different populations have been inconsistent. It is important to note that asthma is a complex condition influenced by many genes, environmental factors, and lifestyle variables. Consequently, a single SNP like rs1042580 rarely acts as a definitive predictor of how a person will respond to a specific medication. Current research emphasizes that genetic markers are just one piece of a much larger puzzle in understanding individual health.
Population Frequency
The rs1042580 variant is classified as a common SNP, meaning it is found at a significant frequency across many different human populations. Because it is common, it is not considered a rare mutation or a disease-causing variant in the traditional sense. Instead, it represents a normal range of genetic diversity found within the human species. Frequencies can vary depending on ancestral background, but the variant is widely distributed globally. This high prevalence is one reason why it has been the subject of extensive pharmacogenomic studies, as researchers aim to understand how such common variations might contribute to the wide range of individual responses observed in clinical settings.
What You Can and Cannot Do With This Information
Understanding your genotype for rs1042580 can be an interesting way to learn about your genetic makeup, but it is not a diagnostic tool. You cannot use this information to predict whether you will develop asthma or to determine how well a specific medication will work for you. Genetic associations are statistical observations made across large groups of people and do not necessarily apply to any single individual. If you have questions about your asthma treatment, your medication dosage, or your respiratory health, you must discuss these concerns with your clinician or pharmacist. They are the only ones qualified to interpret your health history and make decisions regarding your medical care. Never change your medication regimen based on genetic test results without professional medical guidance.
How common is this variant?
The rs1042580 variant is a common polymorphism found across diverse ancestral populations worldwide.
Frequently asked questions
Does rs1042580 cause asthma?
No, rs1042580 is a common genetic variant and is not considered a cause of asthma. Asthma is a complex condition influenced by a combination of many genetic, environmental, and lifestyle factors.
Can I use this SNP to choose my asthma medication?
No, you should not use genetic information to choose or change your medication. Always consult with your doctor or pharmacist to determine the best treatment plan for your specific health needs.
Is rs1042580 the same as other ADRB2 variants?
No, rs1042580 is a specific SNP within the ADRB2 gene. Other variants in the same gene, such as rs1042714, are distinct and have been studied for different potential associations.
Where can I find more information about my genetic results?
You can discuss your genetic results with a qualified healthcare provider or a genetic counselor. They can help you understand the limitations of genetic testing and how it relates to your overall health.
Sources & further reading
Educational information only, last refreshed 10/3/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1042580?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADRB2
Variant in the beta-2 adrenergic receptor linked to metabolic regulation, exercise-induced lipolysis, and endurance performance.
Synonymous polymorphism in the beta-2 adrenergic receptor (Gln27Glu) modulating receptor down-regulation.
The Gln27Glu variant in the beta-2 adrenergic receptor is associated with metabolic and vascular responses to exercise.
Modulates beta-2 adrenergic receptor expression and cardiovascular reactivity.
This variant in the beta-2 adrenergic receptor gene is associated with differential responses to beta-agonist therapy in asthma patients.
Functional variant in the beta-2 adrenergic receptor linked to metabolic rate and cardiovascular reactivity.